In this article we are going to delve into the topic of Benzquinamide. Benzquinamide is a topic that has generated great interest in various areas of society, from politics to science. Throughout history, Benzquinamide has been the subject of multiple research and debate, leading to greater understanding and knowledge on the topic. In this article we will explore different perspectives and approaches related to Benzquinamide, as well as its impact on today's society. From its origin to its future implications, Benzquinamide is a highly relevant topic that deserves to be analyzed in depth.
![]() | |
Clinical data | |
---|---|
Trade names | Promecon, Quantril, Emete-Con |
License data | |
Routes of administration | Suppository, injection |
ATC code |
|
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C22H32N2O5 |
Molar mass | 404.507 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Benzquinamide is a discontinued antiemetic drug used in post-operative care. It was first synthesised by Pfizer in the 1960s.[2] [3]